Affiliations: [a] Division of Neonatology, Department of Pediatrics, Erciyes University Medical Faculty, Kayseri, Turkey
| [b]
Bozok University, Faculty of Medicine, Department of Pediatrics, Yozgat, Turkey
| [c] Division of Pediatric Endocrinology, Erciyes University Medical Faculty, Kayseri, Turkey
Correspondence:
[*]
Address for correspondence: Osman Baştuğ, MD, Department of Neonatology, Erciyes University School of Medicine, Talas C 38039 Kayseri, Turkey. Tel.: +90 0 3522076666; Fax: +90 0 352 4375825; E-mail: [email protected].
Abstract: OBJECTIVES: To assess whether TSH and fT4 have a role in the angiogenesis of vaso-obliteration and neovascularization which are the basic pathophysiology of ROP. METHODS: In this retrospective case-control study, the control group (n = 56) included preterm newborns with risk for ROP while the laser group (n = 63) was recruited from cases who developed severe neovascularization and needed laser photocoagulation therapy. Considering the first (vaso-obliteration) and second (neovascularization) phases of the disease, in this study we researched the distribution of thyroid function tests between groups. RESULTS: With regard to the first phase of the disease, TSH and fT4 showed no significant differences between the control and laser groups accordingly (P > 0.05). Likewise, in the second phase of ROP, there was no significant difference between the control and laser groups with respect to TSH and fT4 levels (P > 0.05). CONCLUSION: We found that between the study groups, the levels of thyroid function tests did not have any significant differences, either in the first or the second phases of ROP which are the principal pathophysiology of the disease. Therefore, it was concluded that thyroid hormone values were not informative markers in the course of the disease in preterm babies at risk of developing ROP.
